Ontario Institute for Cancer Research   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Toronto Canada (2005)

Organization Overview

First Clinical Trial
2014
NCT02017678
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ontario Institute for Cancer Research